معرفی
Dr Venetia Bigley is a Research Fellow at Newcastle University specializing in immunology and hematopoietic stem cell transplantation for primary immunodeficiencies. Her work focuses on dendritic cell and monocyte deficiencies, particularly GATA2-related disorders and CTLA-4 insufficiency, with extensive collaboration through the European Society for Blood and Marrow Transplantation Inborn Errors Working Party.
Her research encompasses:
- Genetic basis of primary immunodeficiencies including DCML deficiency and histiocytic disorders
- Mechanisms of dendritic cell development and function in health and disease
- Optimization of stem cell transplantation protocols for inborn errors of immunity
- Molecular characterization of novel immune dysregulation syndromes
- International registry studies for rare immunological conditions
Analysis of her 2021-2025 publications reveals dominant themes in translational immunology, with emphasis on genetic discovery (GATA2, CARMIL2), therapeutic innovation in stem cell transplantation, and international collaboration for rare diseases. Her work bridges molecular immunology with clinical applications, particularly in hematopoietic disorders requiring transplant intervention.
Scientific Awards: None documented in provided materials.
Advising and Grants: While specific student names and grant details aren't listed, her senior authorship on 50+ publications indicates significant mentorship of junior researchers and likely involvement in major institutional and international funding initiatives supporting immunology and transplantation research.
Labs and Teams: Dr Bigley operates within Newcastle University's Immunology Research Group led by Professor Matthew Collin, maintaining active roles in EBMT Working Parties and European collaborative networks focused on primary immunodeficiencies and histiocytic disorders.